3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets
Stem Cell Reviews and Reports · 2018-04 · 14 (2) · 177-188
DOI: 10.1007/s12015-017-9783-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 27.11.2017. Verfasst von Diana Ribeiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden. Diana.ribeiro@astrazeneca.com. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: FP7 People: Marie-Curie Actions.
Abstract (Originalsprache)
There is a need for physiologically relevant assay platforms to provide functionally relevant models of diabetes, to accelerate the discovery of new treatment options and boost developments in drug discovery. In this review, we compare several 3D-strategies that have been used to increase the functional relevance of ex vivo human primary pancreatic islets and developments into the generation of stem cell derived pancreatic beta-cells (β-cells). Special attention will be given to recent approaches combining the use of extracellular matrix (ECM) scaffolds with pancreatic molecular memory, which can be used to improve yield and functionality of in vitro stem cell-derived pancreatic models. The ultimate goal is to develop scalable cell-based platforms for diabetes research and drug screening. This article will critically assess key aspects related to in vitro pancreatic 3D-ECM models and highlight the most promising approaches for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden. Diana.ribeiro@astrazeneca.com.
- Department of Biology and Bioengineering, Chalmers University of Technology, Gothenburg, Sweden. Diana.ribeiro@astrazeneca.com.
- Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
- Department of Biology and Bioengineering, Chalmers University of Technology, Gothenburg, Sweden.
- Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden. Anna.forslow@astrazeneca.com.
ORCID-Profile: Diana Ribeiro
Förderung
- FP7 People: Marie-Curie Actions
Zitieren
APA
Ribeiro, D., Kvist, A. J., Wittung-Stafshede, P., Hicks, R., & Forslöw, A. (2018). 3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets. Stem Cell Reviews and Reports, 14(2), 177-188. https://doi.org/10.1007/s12015-017-9783-8
Vancouver
Ribeiro D, Kvist AJ, Wittung-Stafshede P, Hicks R, Forslöw A. 3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets. Stem Cell Reviews and Reports. 2018;14(2):177-188. doi:10.1007/s12015-017-9783-8
BibTeX
@article{Ribeiro2018,
author = {Ribeiro, Diana and Kvist, Alexander J and Wittung-Stafshede, Pernilla and Hicks, Ryan and Forslöw, Anna},
title = {3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets},
journal = {Stem Cell Reviews and Reports},
year = {2018},
volume = {14},
number = {2},
pages = {177--188},
doi = {10.1007/s12015-017-9783-8}
}
EUVIMED